Idiopathic Pulmonary Fibrosis for Cardiologists: Differential Diagnosis, Cardiovascular Comorbidities, and Patient Management-Reference-Cited by-同舟云学术

Idiopathic Pulmonary Fibrosis for Cardiologists: Differential Diagnosis, Cardiovascular Comorbidities, and Patient Management

Published:2018-12-15 Issue:2 Volume:36 Page:298-317
ISSN:0741-238X
Container-title:Advances in Therapy
language:en
Short-container-title:Adv Ther

Author:

van Cleemput Johan,Sonaglioni Andrea,Wuyts Wim A.,Bengus Monica,Stauffer John L.,Harari Sergio

Funder

This review was sponsored by F. Hoffmann-La Roche, Ltd.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12325-018-0857-z.pdf

Reference123 articles.

1. Raghu G, Remy-Jardin M, Myers JL, et al. Diagnosis of idiopathic pulmonary fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2018;198(5):e44–68.

2. Dalleywater W, Powell HA, Hubbard RB, Navaratnam V. Risk factors for cardiovascular disease in people with idiopathic pulmonary fibrosis: a population-based study. Chest. 2015;147(1):150–6.

3. Charoenpong P. Risk of coronary artery disease in patients with idiopathic pulmonary fibrosis: a systemic review and meta-analysis. Am J Respir Crit Care Med. 2017;195:A5430.

4. Broder M, Change E, Papoyan E, et al. Risk of cardiovascular comorbidities in patients with idiopathic pulmonary fibrosis: analysis of Medicare data. Eur Respir J. 2016;48(Suppl 60):PA4919.

5. Suzuki A, Kondoh Y. The clinical impact of major comorbidities on idiopathic pulmonary fibrosis. Respir Investig. 2017;55(2):94–103.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of shared molecular mechanisms and diagnostic biomarkers between heart failure and idiopathic pulmonary fibrosis;Heliyon;2024-04

2. Idiopathic pulmonary fibrosis essential biomarkers and immunological infiltration in lung tissue are identified by a bioinformatics analysis;Journal of Intelligent & Fuzzy Systems;2024-02-01

3. Comparison of clinical scoring to predict mortality risk in mild-to-moderate idiopathic pulmonary fibrosis;Minerva Medica;2023-11

4. İdiyopatik pulmoner fibrozisli hastalarda nabız dalga hızı, intima media kalınlığı ve akım aracılı dilatasyon ile kardiyovasküler risk değerlendirmesi;Journal of Medicine and Palliative Care;2023-03-27

5. Prognostic role of CHA2DS2-VASc score for mortality risk assessment in non-advanced idiopathic pulmonary fibrosis: a preliminary observation;Internal and Emergency Medicine;2023-03-25